1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Organoids Services Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Organoids Services Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Organoids Services Market Regional Analysis
6.2 Middle East & Africa Organoids Services Market Revenue 2021-2031 (US$ Million)
6.3 Middle East & Africa Organoids Services Market Forecast Analysis
7. Middle East & Africa Organoids Services Market Analysis – by Type
7.1 Intestine
- 7.1.1 Overview
- 7.1.2 Intestine: Middle East & Africa Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Liver
- 7.2.1 Overview
- 7.2.2 Liver: Middle East & Africa Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Stomach
- 7.3.1 Overview
- 7.3.2 Stomach: Middle East & Africa Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Pancreas
- 7.4.1 Overview
- 7.4.2 Pancreas: Middle East & Africa Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Lung
- 7.5.1 Overview
- 7.5.2 Lung: Middle East & Africa Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Brain
- 7.6.1 Overview
- 7.6.2 Brain: Middle East & Africa Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.7 Kidney
- 7.7.1 Overview
- 7.7.2 Kidney: Middle East & Africa Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Middle East & Africa Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Middle East & Africa Organoids Services Market Analysis – by Application
8.1 Developmental Biology Disease
- 8.1.1 Overview
- 8.1.2 Developmental Biology Disease: Middle East & Africa Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Pathology of Infectious Disease
- 8.2.1 Overview
- 8.2.2 Pathology of Infectious Disease: Middle East & Africa Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Regenerative Medicine
- 8.3.1 Overview
- 8.3.2 Regenerative Medicine: Middle East & Africa Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Drug Toxicity & Efficacy Testing
- 8.4.1 Overview
- 8.4.2 Drug Toxicity & Efficacy Testing: Middle East & Africa Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Drug Discovery & Personalized Medicine
- 8.5.1 Overview
- 8.5.2 Drug Discovery & Personalized Medicine: Middle East & Africa Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Middle East & Africa Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Middle East & Africa Organoids Services Market Analysis – by Source
9.1 Pluripotent Stem Cells
- 9.1.1 Overview
- 9.1.2 Pluripotent Stem Cells: Middle East & Africa Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Organ Specific Adult Stem Cell
- 9.2.1 Overview
- 9.2.2 Organ Specific Adult Stem Cell: Middle East & Africa Organoids Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Middle East & Africa Organoids Services Market – Middle East and Africa Analysis
10.1 Overview
10.2 Middle East and Africa
- 10.2.1 Middle East & Africa Organoids Services Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 10.2.1.1 Middle East & Africa Organoids Services Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 South Africa:
Middle East & Africa Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 South Africa: Middle East & Africa Organoids Services Market Breakdown, by Type
- 10.2.1.1.2 South Africa: Middle East & Africa Organoids Services Market Breakdown, by Application
- 10.2.1.1.3 South Africa: Middle East & Africa Organoids Services Market Breakdown, by Source
- 10.2.1.2 Saudi Arabia:
Middle East & Africa Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Saudi Arabia: Middle East & Africa Organoids Services Market Breakdown, by Type
- 10.2.1.2.2 Saudi Arabia: Middle East & Africa Organoids Services Market Breakdown, by Application
- 10.2.1.2.3 Saudi Arabia: Middle East & Africa Organoids Services Market Breakdown, by Source
- 10.2.1.3 UAE:
Middle East & Africa Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 UAE: Middle East & Africa Organoids Services Market Breakdown, by Type
- 10.2.1.3.2 UAE: Middle East & Africa Organoids Services Market Breakdown, by Application
- 10.2.1.3.3 UAE: Middle East & Africa Organoids Services Market Breakdown, by Source
- 10.2.1.4 Rest of Middle East and Africa:
Middle East & Africa Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Organoids Services Market Breakdown, by Type
- 10.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Organoids Services Market Breakdown, by Application
- 10.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Organoids Services Market Breakdown, by Source
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 CUSABIO TECHNOLOGY LLC
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Cyprio
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Eurofins Scientific SE
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 HUB Organoids B.V. (Hubrecht Organoid Technology)
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 InnoSer
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 InSphero
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 LABTOO
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Molecular Devices, LLC.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Oncodesign Services
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Sino Biological Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations